Abstract
Introduction

All contractility is initiated by changes in the activity of, or interactions of, actin and myosin. In recent years, a multitude of signalling pathways have been suggested to regulate smooth muscle contractility; however, these pathways can be broken down into three major types of mechanisms (Fig. 1): (1) mechanisms that regulate actin-activated myosin ATPase activity via changes in the phosphorylation state of the 20-kD myosin light chain (LC20); (2) mechanisms that regulate the availability of actin to interact with myosin via the action of inhibitory actin-binding proteins such as caldesmon (CaD) and possibly calponin (CaP) and (3) the less well-studied possibility of mechanisms by which the cytoskeleton is remodelled to facilitate the transmission or maintenance of force developed by actomyosin interactions.
The first set of pathways is known to be involved in pathologies such as traumatic brain injury and post-haemorrhagic cerebral vasospasm [1, 2] (discussed in detail in a review by Jose Rafols in this series), and in pulmonary hypertension [3] . The second set of pathways is strongly implicated in pre-term labour [4] . The third set of pathways is implicated in asthma [5] . Thus, the diversity of signalling pathways that regulate contractility may well offer opportunities for discovery of potential disease-and organ-specific therapies.
The first set of mechanisms is illustrated on the left-hand side of Fig. 1 pathway, leads to pulmonary artery hypertension [3] . MYPT1 phosphorylation in particular has been shown to be sensitive to hypoxia, thus probably playing an essential role in hypoxic relaxation [66] . In hypertensive rat models, inhibition of the Rho pathway corrected the hypertension [67] . In the setting of neonatal circulatory transition and in persistent pulmonary hypertension of the newborn, the Rho pathway appeared to be less important, but instead a role for CPI-17 was shown [68] . (Fig. 3) . The association domains of all isoforms of CaMKII interact to form large wheel-shaped holoenzymes [70] . Crystallographic data indicate that the holoenzyme is dodecameric [71] .
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As [96] .
Recent work on the ␦-isoform of CaMKII has shown a role for CaMKII-␦ in PDGF-stimulated vascular smooth muscle migration [97] and wound healing [98] . Vascular injury induced by balloon angioplasty has been shown to increase CaMKII-␦ isoform expression in smooth muscle cells and in fibroblasts [99] . Trafficking of iNOS was also shown to be dependent on the activation of CaMKII-␦ isoform [100] . Thus, the ␥-and ␦-isoforms of CaMKII may have distinct, but equally important roles in vascular function.
Mechanisms that regulate the access of myosin to actin Caldesmon
CaD is a highly conserved, actin- [101] and myosin- [102] binding protein that exists in two isoforms which are generated by alternative splicing. Whereas the heavy isoform (h-CaD) is restricted to smooth muscle cells, the light isoform (l-CaD) is expressed in non-muscle and de-differentiated smooth muscle cells [103] . This thin-filament associated protein is capable of stabilizing actin filaments [104] , blocking Arp2/3 mediated actin polymerization [105] , inhibiting actomyosin ATPase activity [106] as well as actin-myosin interaction [107] [108] or by phosphorylation of Serine residues 759 and 789 by either ERK1/2 [109] or cdc2 [110] . These events lead to a conformational change in the CaD structure which allows interaction between actin and myosin [111] . While cdc2 phosphorylation plays an important role in cytokinesis [112] , the phosphorylation of CaD by ERK1/2 appears to regulate smooth muscle contractility [113] . In this latter process ERK1/2 is activated by PKC ( Fig. 1 [120, 121] , although the other isoforms are also expressed in this cell type in a lower extent [119, 122] . Moreover bCaP can be used as a differentiation marker of smooth muscle due to its down-regulation in proliferating cells [87] . [123, 124] . The very C-terminus is the variable region in the three CaP-isoforms, whereas the N-terminal fragment is highly conserved (see Fig. 4 ). The CH-domain has been shown to bind acidic phospholipids [125] and ERK1/2 [126] , although this structural motif is often implicated in actin binding in many other cytoskeleton proteins [127] . PKC-␣ and -ε can interact with bCaP through the C-terminal repeats [128] . Actin binding of CaP occurs through the TnI-like domain and in a weaker fashion through the C-terminal repeats [124] and is regulatable by phosphorylation of PKC at Serine 175 and Threonine 184 residues located within the C-terminal repeats [129, 130] . [128] and ERK1/2 [126] , cotranslocates to the cell cortex upon stimulation together with ERK1/2 and PKC [132] and, in addition, seems to promote PKC activation [128] . Moreover [134] [135] [136] . On the other hand, active MAPKs have also been found in differentiated, non-proliferating contractile smooth muscle cells [137, 138] , but their function in this cell types is still not fully understood. Furthermore it is interesting that an intact actin cytoskeleton seems to be necessary for ERK signalling [139] and that ERK1/2 itself shows actin-binding properties [126] , suggesting that the actin cytoskeleton is involved in ERK1/2 signalling. More evidence for ERK1/2 playing a significant role in regulation of smooth muscle contractility comes from studies in pregnant rats showing that ERK1/2 activity is connected to onset of labour [140] . In uterine smooth muscle, the kinase is activated in late pregnancy, possibly due to an increased cortical tension, after translocation to the cell surface. This event is followed by an increased h-CaD phosphorylation which contributes to the initiation of contractions [4, 25] .
CaP proteins consist of a conserved so called CaP homology (CH) domain in their N-Terminus, a Troponin I (TnI) -like actin-binding domain and three C-terminal repeats
Another [141] .
The model shown in Fig. 5 [113] . [145] . Further examination has revealed that these mice display a faster shortening velocity [146] , a lower heart beat rate, an impaired ␣-adrenergic vasoconstriction, an enhanced arterial baroreflex sensitivity [147] , a lower active isometric force [148] as well as impaired arterial blood pressure regulation during exercise due to an enhanced muscular vasodilation [149] .
Less is known about bCaP and its involvement in vascular diseases, but hints come from mice with a mutated bCaP locus which express a C-terminal truncated form of the protein lacking the TnIlike domain as well as the three C-terminal repeats and the variable C-terminus. Surprisingly the most conspicuous phenotype of these mice was an increased bone formation, leading to the hypothesis that bCaP is involved in regulation of osteogenesis
Particularly the enhanced vasodilation in mice expressing the truncated bCaP form is consistent with our hypothesis that bCaP is required to activate ERK1/2 which in turn inactivates h-CaD, thereby facilitating contraction. However, it should be considered that the truncated bCaP protein expressed in the mouse model lacks only the actin-binding domains and the CH-domain is still expressed. So it should be examined if this truncated bCaP form is still able to interact with ERK1/2 and could therefore substitute for the wildtype bCaP in some of its functions.
In other studies, it has been shown that blood vessels of mice with a mutated bCaP locus are more fragile [150] and therefore less resistant to metastasis of tumour cells [151, 152] . Indeed down-regulated bCaP expression is a poor diagnostic marker in many cancers [153] [154] [155] [156] [157] [158] [159, 160] [162] [163] [164] . (Fig. 6) [165, 166] . [164] . This result is consistent with the findings reported by Gunst and colleagues for airway smooth muscle [167, 168] .
, leading to the hypothesis that misregulated bCaP levels are connected to cancerous diseases. It has been speculated that down-regulated bCaP levels in smooth muscle cells of blood vessel tumours leads to a destabilization of actin filaments, thereby weakening adhesion of cells to neighbouring cells as well as to the extracellular matrix. This in turn could be a reason for the fragility and penetrability of metastatic tumour cells [150]. On the other hand it was also shown that restoration of bCaP expression in transformed cells can lead to a reduced proliferation rate, tumourigenicity and metastatic cell motility. It has also been speculated that a loss of bCaP leads to an unstable actin filament system, thereby facilitating cytoskeleton reorganisation which is necessary for cells to assume an invasive phenotype
. Finally, given the evidence (mentioned above) that CaP interacts with MAPKs and the known association of MAPKs with regulation of proliferation, this pathway could also contribute to this property of CaP. Thus, the exact mechanisms by which bCaP can act as a tumour suppressor remains to be elucidated.
Mechanisms that regulate cytoskeletal remodelling
The actin cytoskeleton is defined as the collection of actin filaments and actin filament associated proteins, including adhesion plaque proteins. It has previously been assumed that the actin cytoskeleton in dSMC is largely static, performing a solely structural role, in comparison to the dynamic cytoskeleton of migrating, proliferating vascular smooth muscle cells [161]. Although this topic is still controversial, a body of evidence is growing to support the idea that the actin cytoskeleton is remodelled during contractile agonist activation and that this remodelling might modulate vascular contractility
Actin can exist as either filamentous actin (F-actin) or globular actin (G-actin) in cells. G-actin spontaneously polymerizes to form F-actin above its critical concentration (~8 g/ml) [165]. The G-actin concentration in the cytoplasm of dVSM cells is above the critical concentration. However, the polymerization of actin is tightly controlled by a large number of actin-binding proteins such as profilin, ADF/cofilin, capping proteins, and sequestering proteins, etc. Signalling pathways that regulate these processes therefore regulate the actual ratio between G-and F-actin resulting in assembly or disassembly of the actin filament
Actin exists primarily as F-actin (~80% of total actin) in unstimulated contractile intact vascular smooth muscle. The percentage of F-actin can go above 90% in ␣-adrenergic receptor stimulated smooth muscle, indicating dynamic remodelling of the actin cytoskeleton
Actin is the most abundant protein in smooth muscle and it is highly conserved throughout evolution and across species [169] . Six actin isoforms, products of separate genes, are present in vertebrate tissues [170] . Among these isoforms, two smooth muscle type isoforms (␣ and ␥) and two cytoplasmic isoforms (␤ and ␥) coexist in differentiated vascular smooth muscle [164, 171] . The cytoplasmic ␤-and ␥-actin isoforms are also sometimes referred to as non-muscle isoforms in smooth muscle tissues [169] . Evidence exists, largely in cultured non-muscle cells that the different actin isoforms perform different cellular functions [169] . The amino acid sequences of these actin isoforms are remarkably conserved and most sequence differences are clustered at the NH2-terminal ends [172] . [173] [174] . A differential subcellular distribution of ␣-smooth muscle and ␤-cytoplasmic actin in vascular smooth muscle [175] and a differential distribution for ␤-cytoplasmic actin from actomyosin containing contractile bundles in chicken gizzard smooth muscle [174] have been reported. A separation of cytoskeletal actin from actomyosin-containing contractile actin has been reported by using immunoprecipitation [176] . In contrast, others have argued against any actin isoform-specific domains in vascular smooth muscle [177] [178] [179] . It is quite likely that the connection between the two actin cytoskeletons is dynamic perhaps regulated by 'a hierarchical slippage clutch' that is, itself, regulated by signalling pathways [180] .
The NH2-terminal region of actin is known not to be involved in actin-actin monomer binding and hence does not directly regulate actin filament polymerization; however, this region is known to be the binding site of many actin-binding proteins including myosin
Focal adhesion complexes are large structures, often a micron in size, containing, in different cell types, over a hundred proteins including integrin, actin, actin-binding proteins, protein kinases, and signalling proteins (Fig. 6) [181] . consists of 18 ␣-and 8 ␤-subunits which can form 24 unique integrin heterodimers [182] . The short intracellular domains of integrins are indirectly connected to the actin cytoskeleton by several proteins such as talin, vinculin, paxillin and by these connections, the extracellular events can be communicated into the cell and vice versa [183] . Further details on this topic can be found in other recent review articles [181, [183] [184] [185] .
At focal adhesions, the force generated by the contractile proteins is conveyed to the extracellular matrix (ECM) via integrin receptors. The integrin family © 2008 The Authors Journal compilation © 2008 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
There [163, [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] .
Actin cytoskeletal remodelling also has been reported to occur in vascular smooth muscle [162, 164, 189, 190, 196] [192] . Dynamic cytoskeletal processes within the cell may enhance the strength of the connections between membrane adhesion junctions and actin filament within the contractile apparatus and cytoskeletal network, thus providing a strong and rigid framework for the transmission of force generated by the interaction of myosin and actin filaments to the outside of the cell [167] . However, Seow and his colleagues have published that the length of total contractile filament complex is changed by addition or removal of myofilament units, suggesting the possibility of dynamic remodelling in actomyosin containing myofilament [197] [198] [199] [200] [201] [202] . Other groups have suggested that cytoskeletal remodelling modulates force maintenance or optimizes the energetic cost of tension in the vascular smooth muscle cell [203] .
Recently, we found that the actin cytoskeleton in vascular smooth muscle is differentially remodelled in a stimulus-and pathway-dependent manner. Interestingly, ␥-actin, the least abundant actin isoform in vascular smooth muscle, is the most dynamically remodelled by ␣-adrenergic receptor stimulation [164] . This result suggests that the non-muscle actin cytoskeleton is more dynamic than the actin cytoskeleton in contractile apparatus. The reorganization of the cytoskeleton was shown to correlate with mechanisms for regulation of smooth muscle contraction.
To understand the functional specificity of individual actin isoforms and to identify the isoforms related diseases, several investigations utilized manipulation of the isoform-specific genes [204] [205] [206] . Ablation of ␥-cytoplasmic actin in skeletal muscle causes progressive muscle necrosis and regeneration in mouse [207] [208] [209] . Vascular smooth muscle contractility and blood pressure homeostasis are impaired in the ␣ smooth muscle actin null mouse [206] .
It is conceivable that abnormal contractility in vascular smooth muscle may result from the perturbation of normal cytoskeletal remodelling processes. Recently, Guo et al. [210] published that 14% of inherited familial ascending thoracic aorta aneurysms leading to acute aortic dissections are caused by missense mutations in ACTA2 (encodes ␣ smooth muscle actin). By using structural and immunofluorescence analysis, this study show that interference with actin filament polymerization caused by this mutation leads to impaired smooth muscle contraction [210] . There is much experimental evidence supporting the concept that remodelling of the actin cytoskeleton is a crucial regulator of smooth muscle function. However, much remains to be determined regarding the mechanistic basis for the actin cytoskeletal remodelling in smooth muscle.
Conclusions
Undoubtedly, the information above has communicated the concept that smooth muscle 'excitation-contraction coupling ' 
